𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum α-L-fucosidase activity and tumor size in hepatocellular carcinoma

✍ Scribed by Hirofumi Takahashi; Toshiji Saibara; Shinichi Iwamura; Akira Tomita; Takashi Maeda; Saburo Onishi; Yasutake Yamamoto; Hideaki Enzan

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
382 KB
Volume
19
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum α-L-fucosidase activity and early
Serum α-L-fucosidase activity and early detection of hepatocellular carcinoma : A prospective study of patients with cirrhosis
✍ Maria G. Giardina; Margherita Matarazzo; Roberto Morante; Antonio Lucariello; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. Serum ␣-L-fucosidase activity is considered a marker of hepatocellular carcinoma. To the authors' knowledge, its clinical usefulness in the early detection of hepatocellular carcinoma in the follow-up of cirrhotic patients has not been reported previously. ## METHODS. The authors

Relationship between α-L-fucosidase defi
Relationship between α-L-fucosidase deficiency in plasma and α-L-fucosidase activity in leukocytes
✍ Rosanna Gatti; Silvia Cavalieri; Giovanni Romeo 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 409 KB

After testing a population sample of 185 hospitalized Italian children for the plasma alpha-L-fucosidase deficiency and establishing an approximate threshold value between heterozygotes and wild-type homozygotes, we analyzed by two statistical methods the distribution of the two genotypes. The resul

Serum endostatin predicts tumor vascular
Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
✍ Mesut Tez; Selda Tez 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

We agree that the measurement of serum endostatin can predict tumor vascularity and may serve as a promising tool in antiangiogenic therapy for patients with HCC. At the same time, the 184-amino acid proteolytic fragment of the carboxy terminus of C18, endostatin, has been identified as a potent en

Serum α-L-Fucosidase: A New Marker for t
Serum α-L-Fucosidase: A New Marker for the Diagnosis of Primary Hepatic Carcinoma?
✍ Yves Deugnier; Véronique David; Pierre Brissot; Philippe Mabo; Damien Delamaire; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

alpha-L-fucosidase, a lysosomal enzyme which catabolizes fucoproteins, was studied in sera from 30 controls, 32 patients with primary hepatic carcinomas, 24 patients with secondary metastatic liver carcinomas and 36 patients with cirrhosis. Serum alpha-L-fucosidase was increased in primary hepatic c